RT @moosemousa: As therapies evolve and men with advanced prostate cancer live longer, screening for adverse effects associated with androg…

RT @RKSayyid: JCOG1019: Non-inferiority ph 3 RCT of WW vs BCG in primary T1 NMIBC pts w/ T0 on repeat TUR (n=263) 🔹Primary endpoint: No di…

RT @NEJM: AMBASSADOR trial: After cystectomy, patients with muscle-invasive bladder cancer were randomly assigned to pembrolizumab or obser…

@VanProstateCtr Congratulations @pcvblack! Well deserved.

@a_koven @CleClinicUro Congratulations Alex!!!

RT @WallisCJD: As July rounds to an end @UofTUrology is saying goodbye to our @UroOnc fellows - @chavarriagaj @RKSayyid and Ravi Kumar: it…

@WallisCJD @dieworkwear Congratulations @WallisCJD You’re a superstar!

RT @WallisCJD: No collar gaps to be found @dieworkwear

RT @WallisCJD: Big topic with upcoming meetings. Let us know what you think - does the political/legislative environment affect your inte…

RT @tompowles1: Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of de…

RT @WallisCJD: New online this morning in @JAMASurgery: Our latest work examines the effect of surgeon sex on heal…

RT @globalnewsto: According to a study conducted by the @cancersociety, over 25,000 Canadian men are expected to be diagnosed with prostate…

RT @tompowles1: Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st lin…

RT @TrungTPhan: Kelvin Kiptum just ran a record marathon time of 2:00:35 in Chicago. He beat Eliud Kipchoge’s 2:01:09 time by 34 secs! And…

RT @WallisCJD: What a pleasure to collaborate with @arghavan_salles Much more to come

Very lucky to have the best team supporting me as I somehow made it through my first week of operating as staff! @UHN and good luck to Rohan as he embarks on his new path to become an NP!

RT @chavarriagaj: Kudos to @drrajvtiwari @AHirdMD and @KhattiA for completing their @SUO_YUO fellowship. We were so fortunate to have you…

RT @BladderCancerUS: This is huge. SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymph…

@AmerUrological Congratulations @RyanFlannigan00

@pcvblack @GSK_UofT @UBCUrology @VanProstateCtr @BladderCancerCA @halfwaytocina @MariePierStLau1 @MTDawidek @JonoSuds @MilesMannas Love this! My two urology worlds colliding!